Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BHV-7000 in acute manic episodes of bipolar I disorder
NCT06419582Phase 3Completed
- Sponsor
- Biohaven Ltd.
- Start
- May 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing BHV-7000 with Placebo (2 arms). Primary endpoint: Young Mania Rating Scale at 21 days. Started May 2024; status: completed.
02
Drugs
opakalim
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT06419582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06419582.